Role of human neutrophil gelatinase associated lipocalin (NGAL) and Matrix Metalloproteinase-9 (MMP-9) overexpression in neoplastic colon polyps

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 9, 2014, Pages 2804-2811

  Odabasi, Mehmet ^a   Yesil, Atakan ^a   Ozkara, Selvinaz ^a   Paker, Nurcan ^b   Ozkan, Sevil ^a   Eris, Cengiz ^a   Yildiz, Mehmet Kamil ^a   Abuoglu, Hacı Hasan ^a   Gunay, Emre ^a   Tekeşin, Kemal ^a  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Duzen Laboratories   (Turkey)

Author keywords

Colorectal polyps; MMP 9; NGAL

Indexed keywords

GELATINASE B; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; CANCER INCIDENCE; CANCER STAGING; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PERINEURAL INVASION; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84907833693     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
2. Sun Y, Yokoi K, Li H, Gao J, Hu L, Liu B, Chen K, Hamilton SR, Fan D, Sun B, Long N, Moore Chen W, Gao CM, Lai MS, Mizoue T, Oyunchimeg D, Park S, Shin HR, Tajima K, Yoo KY, Sobue T. Cancer epidemiology and control in north-East Asia past, present and future. Asian Pac J Cancer Prev 2010; 11 Suppl 2: 107-48.
3. Roya N, Abbas B. Colorectal cancer trends in kerman province, the largest province in Iran, with forecasting until 2016. Asian Pac J Cancer Prev 2013; 14: 791-3.
4. Morrison DS, Parr CL, Lam TH, Ueshima H, Kim HC, Jee SH, Murakami Y, Giles G, Fang X, Barzi F, Batty GD, Huxley RR, Woodward M. Behavioural and metabolic risk factors for mortality from colon and rectum cancer: analysis of data from the Asia-pacific cohort studies collaboration. Asian Pac J Cancer Prev 2013; 14: 1083-7.
5. Eser S, Yakut C, Ozdemir R, Karakilinc H, Ozalan S, Marshall SF, Karaoglanoglu O, Anbarcioglu Z, Ucuncu N, Akin U, Ozen E, Ozgul N, Anton-Culver H, Tuncer M. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Pre 2010; 11: 1731-9.
6. Yamamoto M, Mine H, Kusumoto H, Maehara Y, Sugimachi K. Polyps with different grades of dysplasia and their distribution in the colorectum. Hepatogastroenterology 2004; 51: 121-3.
7. Harima S, Hashimoto S, Shibata H, Matsunaga T, Tanabe R, Terai S, Sakaida I. Correlations between obesity/metabolic syndrome-related factors and risk of developing colorectal tumors. Hepatogastroenterology 2013; 60: 733-7.
8. Park SY, Kim BC, Shin SJ, Lee SK, Kim TI, Kim WH. Proximal shift in the distribution of adenomatous polyps in Korea over the past ten years. Hepatogastroenterology 2009; 56: 677-81.
9. Crispin A, Mansmann U, Munte A, Op den Winkel M, Goke B, Kolligs FT. A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies. Digestion 2013; 87: 170-5.
10. Kjeldsen L, Bainton DF, Sengeløv H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994; 83: 799-807.
11. Goetz DH, Willie ST, Arme RS, Bratt T, Borregaard N, Strong RK. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 2000; 39: 1935-41.
12. Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005; 123: 1293-1305.
13. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10: 1045-56.
14. Bolignano D, Coppolino G, Donato V, Lacquaniti A, Bono C, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? Med Sci Monit 2010; 16: 131-5.
15. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10: 1033-43.
16. Martines AM, Masereeuw R, Tjalsma H, Hoenderop JG, Wetzels JF, Swinkels DW. Iron metabolism in the pathogenesis of iron-induced kidney injury. Nat Rev Nephrol 2013; 9: 385-98.
17. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996; 38: 414-20.
18. Conrotto P, Roesli C, Rybak J, Kischel P, Waltregny D, Neri D, Castronovo V. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer 2008; 123: 2856-64.
19. Bratt T. Lipocalins and cancer. Biochim Biophys Acta 2000; 1482: 318-26.
20. Yesil A, Gonen C, Senates E, Paker N, Gokden Y, Kochan K, Erdem ED, Gunduz F. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity. Dig Dis Sci 2013; 58: 2587-93.
21. Oikonomou KA, Kapsoritakis AN, Theodoridou C, Karangelis D, Germenis A, Stefanidis I, Potamianos SP. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol 2012; 47: 519-30.
22. Barresi V, Lucianò R, Vitarelli E, Labate A, Tuccari G, Barresi G. Neutrophil gelatinase-associated lipocalin immunoexpression in colorectal carcinoma: A stage-specific prognostic factor? Oncol Lett 2010; 1: 1089-96.
23. Martí J, Fuster J, Solà AM, Hotter G, Molina R, Pelegrina A, Ferrer J, Deulofeu R, Fondevila C, García-Valdecasas JC. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer. World J Surg 2013; 37: 1103-9.
24. Zhang XF, Zhang Y, Zhang XH, Zhou SM, Yang GG, Wang OC, Guo GL, Yang GY, Hu XQ. Clinical significance of Neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cancer. BMC Cancer 2009; 9: 134.
25. Sun Y, Yokoi K, Li H, Gao J, Hu L, Liu B, Chen K, Hamilton SR, Fan D, Sun B, Zhang W. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res 2011; 17: 4331-40.
26. Bolignano D, Donato V, Lacquaniti A, Fazio MR, Bono C, Coppolino G, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 2010; 288: 10-6.